Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001628280-25-018892
Filing Date
2025-04-22
Accepted
2025-04-22 17:23:41
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-1 intensity-sx1.htm S-1 477625
2 EX-FILING FEES exhibit107-sx1.htm EX-FILING FEES 26723
3 EX-1.1 exhibit11-sx1.htm EX-1.1 70390
4 EX-4.4 exhibit44-sx1.htm EX-4.4 136471
5 EX-4.5 exhibit45-sx1.htm EX-4.5 136477
6 EX-4.6 exhibit46-sx1.htm EX-4.6 115930
7 EX-5.1 exhibit51-sx1.htm EX-5.1 17412
8 EX-10.16 exhibit1016-sx1.htm EX-10.16 264408
9 EX-23.1 exhibit231-sx1.htm EX-23.1 2906
10 logo1b.jpg GRAPHIC 8006
11 mintzlogo.jpg GRAPHIC 10797
12 prospectuscovera.jpg GRAPHIC 10015
  Complete submission text file 0001628280-25-018892.txt   1289503
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-286683 | Film No.: 25858621
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)